NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
04/26/2024
Back to search
Official data from USPTO
AMERSHAM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
AMERSHAM
ST13
US500000076410122Class
1, 5, 9, 10, 42, 44
Filing
76410122
Registration
2807878
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
04/26/2024
Trademark type
Word
Nice classes
1, 5, 9, 10, 42, 44
Filing date
05/20/2002
Registration date
01/27/2004
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/26/2024
Last transaction
04/26/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
Drawing code
1
Owner type
99
Owner location
Buckinghamshire, GB
Examiner
BELL, MARLENE
Law office
L50
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
GLOBAL LIFE SCIENCES SOLUTIONS OPERATIONS UK LTD
GE HEALTHCARE LIMITED
AMERSHAM PLC
Representatives
Dyan M. House Baker & Mckenzie, LLP
Technical classification
Nice Classes
Class 1Class 5Class 9Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicalsbiochemicals and reagents for use in industryscience and researchnucleotidesfluorescent nucleotidesoligonucleotidespeptidesproteinsamino acidsorganic moleculesmarkers for DNA/RNA synthesis; reagents for luminescence; reagents for gene expression quantification; reagents for use with the polymerase chain reactionPCRprocess and the rolling circle amplification (RCA) process; reagents for cDNA cloning vectorsmodifying and restriction enzymes; reagents for labelingdetecting sequencing and fragment analysis of nucleic acidsproteinscustom synthesis; reagents for recombinant protein expression purificationchromatography media; electrophoresis; spectrophotometry and fluorometry; radiochemicals; scintillation assays; and high through put screening assays for drug development; and chemical preparations and substances for use in the manufacture of pharmaceutical products; diagnostic preparations and substances; chemical test reagentssaline solution and reagent-coated paperall for scientific and laboratory use; fissionable chemical elements; radioactive elements and isotopes for industrialscientificresearch purposes; radioactive sources and standards for use in radiographic techniques; radioactive sources for use in non-destructive testingpurification or sterilizing techniques for use in industryscience and research; chemical preparationskits and reagents for analysis or diagnosis used for scientific purposescell separation and culture; nucleic acid purification ; and radionuclidesgases and gas mixtures for industrialscientificresearch purposes
Class 5
Diagnostic agentspreparations and substances for medical purposes; Contrast media for medical imaging; diagnostic scanning agents for in vivo use; radiopharmaceutical products for clinicalmedical and research use; radioactive sources and standards for use in nuclear medicine; radioactive pharmaceutical preparations and non-radioactive reagents for producing radiopharmaceuticals for in vivo diagnostic or therapeutic use; pharmaceutical preparations for use in diagnosis; pre-filled vials and cartridges containing medical diagnostic reagents or saline solution; and radioisotope brachytherapy substances
Class 9
Scientific apparatus and instruments used for radiology for the purpose of measuringmonitoring and surveying; computersprinterssoftware programs used for the purpose of life science research and for nuclear cardiology and medical imagingfor use by laboratoriespharmaciesdoctorshospitalsmedical service providers; radiology apparatus and instruments for the reading and interpretation of autoradiographs and filmsautomated film readers and scanners; apparatus for electrophoresis; chromatography columns and pumps; apparatus for microfabrication; apparatus for scintillation; imaging apparatus for radioactive and luminescent emissions; synthesis and purification integrated systems for use in radiology; apparatus for manufacturing oligonucleotides; apparatus for microarrays; microarray slides; laboratory glassware; laboratory vials and microvials; microtitre plates; and parts and fittings for the aforesaid goods
Class 10
Surgicalmedicaldentalveterinary apparatus and instruments used for the purpose of measuringmonitoring and surveying in the field of radiotherapycomprised of medical needlessuture needlesimplantable radiation therapy devices and implantable radiation therapy devices consisting of encapsulated radioisotope brachytherapy sourcesradiation therapy delivery system consisting primarily of radioactive seeds and a bio-absorbable carrier assembly; magnetic resonance imagersMRI; x-ray apparatus for medical use; x-ray diagnostic apparatuscomputerized tomographyCAT scanners and ultrasound imagers; radiological apparatus for diagnostic and medical purposes; diagnostic and test kits for clinical medical use comprised of test tubestest plates and indicator charts for evaluating test results; vials; cannulas; needles and syringes; injectors; cartridges; infusion pumps for intravenous administration of fluids; needles for medical purposes; and parts and fittings for the aforesaid goods
Class 42
Advisory services for pharmaceutical companies in the field of purification and chromatography; research and development services in the field of pharmaceutical and life sciences; research and product development for othersresearch and development of pharmaceuticalmedicalveterinary preparationsdiagnostic media and agents for use in medical and diagnostic imaging; consultancy services relating to chemical and pharmaceutical research; analytical services in the fields of medicinepharmaceuticals and biochemistry; radiolableling servicesisotopic labeling of biological molecules; pharmaceutical drug development services for pharmaceutical companies and medical professionals
Class 44
Medical diagnostic services; medical imaging services; providing medical and medical product information to pharmaceutical companies and medical professionals
Publications
History of USPTO decisions and trademark events.
38 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
04/26/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
04/26/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/26/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
12/28/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/22/2023
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
09/22/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/22/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/22/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/22/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/22/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/27/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
10/07/2020
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
07/28/2014
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
07/28/2014
9G8P
REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
07/28/2014
8PRT
REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
07/28/2014
E89R
TEAS SECTION 8 & 9 RECEIVED
07/24/2014
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
02/11/2010
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/10/2010
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
02/02/2010
E815
TEAS SECTION 8 & 15 RECEIVED
02/02/2010
CFIT
CASE FILE IN TICRS
06/07/2007
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/18/2005
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/18/2005
R.PR
REGISTERED-PRINCIPAL REGISTER
01/27/2004
PUBO
PUBLISHED FOR OPPOSITION
11/04/2003
NPUB
NOTICE OF PUBLICATION
10/15/2003
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/24/2003
CNEA
EXAMINERS AMENDMENT MAILED
06/24/2003
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
06/16/2003
1.BD
Sec. 1(B) CLAIM DELETED
03/21/2003
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/10/2003
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/28/2003
PAPER RECEIVED
01/28/2003
CNRT
NON-FINAL ACTION MAILED
12/06/2002
CNEA
EXAMINERS AMENDMENT MAILED
11/27/2002
CNRT
NON-FINAL ACTION MAILED
08/27/2002
Continuous trademark protection
Get notified about every new filing that threatens AMERSHAM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.